Skip to main content
. Author manuscript; available in PMC: 2019 Sep 20.
Published in final edited form as: J Hum Hypertens. 2019 Mar 20;33(5):411–418. doi: 10.1038/s41371-019-0193-z

Table 2. Association of SBP variability with unfavorable shift of the mRS at 90 days.

Univariate analysis Multivariate Model
OR(95%CI) P value OR(95%CI) P value
Mean 1.26(1.21-1.31) <0.0001 1.21(1.16-1.25) <0.0001
MIN 1.18(1.14-1.23) <0.0001 1.15(1.11-1.20) <0.0001
MAX 1.28(1.23-1.33) <0.0001 1.21(1.16-1.26) <0.0001
SD 1.17(1.12-1.23) <0.0001 1.10(1.05-1.15) <0.0001
CV 1.11(1.06-1.15) <0.0001 1.06(1.02-1.10) 0.0065
ARV 1.17(1.11-1.22) <0.0001 1.12(1.06-1.17) <0.0001
RSD 1.13(1.08-1.18) <0.0001 1.08(1.04-1.13) 0.0002
VIM 1.08(1.04-1.13) <0.0001 1.04(1.00-1.08) 0.0533

CV: coefficient of variation; ARV: average absolute difference between successive BP measurements; RSD: residual SD; VIM: variation independent of mean.

Data are presented as odds ratio [OR] (95% confidence intervals [95%CI]) for per 1 unit increment of systolic blood pressure [SBP] variability (i.e. for SD, the unit is 1 SD of SD; for CV, the unit is 1 SD of CV; for ARV, the unit is 1 SD of ARV; for RSD, the unit is 1 SD of RSD; and for VIM, the unit is 1 SD of VIM).

Multivariable Model: Adjusted for country, prestroke mRS score, sex, baseline NIHSS score, and history of heart disease, stroke, diabetes mellitus, or hypertension, prior antiplatelet therapy